Cargando…
Clinical Phenotypes Characterization in Pharmacogenetics Testing Trials for Major Depressive Disorder Treatment
Several data indicate that the success of pharmacological treatment in major depressive disorder (MDD) is still unsatisfactory. The determination of the optimal treatment generally requires multiple trials with different treatments, with the sobering observation that the more treatments tried withou...
Autor principal: | Minelli, A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9566862/ http://dx.doi.org/10.1192/j.eurpsy.2022.137 |
Ejemplares similares
-
The role of pharmacogenetics in the treatment of major depressive disorder: a critical review
por: Barlati, Stefano, et al.
Publicado: (2023) -
Cost-Effectiveness of a Pharmacogenetic Test to Guide Treatment for Major Depressive Disorder
por: Groessl, Erik J., et al.
Publicado: (2018) -
Efficacy of prospective pharmacogenetic testing in the treatment of major depressive disorder: results of a randomized, double-blind clinical trial
por: Pérez, Víctor, et al.
Publicado: (2017) -
Pharmacogenetics to Personalize Dosing of Tricyclic Antidepressants in Major Depressive Disorder: A Randomized Clinical Trial (PITA study)
por: Ter Hark, S., et al.
Publicado: (2023) -
The utility of pharmacogenetic testing to support the treatment of bipolar disorder
por: Ielmini, Marta, et al.
Publicado: (2018)